Table 2 The baseline characteristics of the FAS population of the three groups of patients
Characteristic | YWF | YWF + gypsum | Allopurinol | F value | |
|---|---|---|---|---|---|
Age (years) | 45.33 ± 9.86 | 46.13 ± 10.75 | 49.21 ± 9.47 | 1.00 | |
Gout history (months) | 39.42 ± 29.00 | 55.25 ± 36.58 | 42.96 ± 32.38 | 1.54 | |
sUA (μmol/L) | 562.29 ± 108.29 | 585.46 ± 100.06 | 618.00 ± 114.27 | 1.62 | |
Urine urate (mmol/24 h) | 7.80 ± 0.37 | 7.79 ± 0.33 | 7.78 ± 0.31 | 0.01 | |
CRP (mg/L) | 13.13 ± 2.63 | 14.03 ± 3.40 | 13.15 ± 1.13 | 0.33 | |
ESR (mm/h) | 8.96 ± 4.99 | 8.79 ± 3.16 | 9.88 ± 6.96 | 0.29 | |
SF-36 scale | BP | 25.00 ± 14.52 | 31.71 ± 11.74 | 26.96 ± 9.54 | 1.95 |
RP | 27.08 ± 23.22 | 22.92 ± 19.39 | 25.00 ± 23.31 | 0.21 | |
PF | 78.96 ± 7.07 | 81.04 ± 9.44 | 77.50 ± 10.11 | 0.95 | |
VT | 73.13 ± 7.91 | 75.83 ± 9.85 | 75.42 ± 9.20 | 0.63 | |
SF | 41.15 ± 22.87 | 43.23 ± 17.28 | 42.71 ± 20.16 | 0.07 | |
RE | 19.43 ± 21.79 | 26.38 ± 24.04 | 24.99 ± 22.52 | 0.95 | |
GH | 64.79 ± 13.95 | 66.04 ± 12.70 | 59.71 ± 14.43 | 1.44 | |
MH | 43.67 ± 15.78 | 46.17 ± 15.78 | 46.42 ± 16.23 | 0.22 | |